Latest Financials News

Mayne Pharma has settled patent litigation with Sun Pharma over IMVEXXY, establishing 21 October 2032 as the agreed potential generic entry date, subject to court approval. The settlement involves no upfront payment, while one further Paragraph IV dispute remains unresolved.

Paradigm Biopharmaceuticals has entered voluntary administration after its pivotal Phase 3 trial produced an interim efficacy result below the threshold required for continuation. The company’s securities will remain suspended while administrators assess its viability, liabilities and possible restructuring options.

Papyrus Australia has produced a second batch of TBS board samples, expanded pulp capacity in Adelaide and secured additional funding as it moves towards commercial supply. The progress comes with testing still incomplete and an estimated 4.87 months of funding available.

Felix Gold advanced bulk extraction, processing and refinery plans at its Alaska antimony project in FY26, but the push came with a larger loss, falling cash and an auditor-documented material uncertainty over going concern. A potential US$18 million Department of Energy award remains subject to negotiation rather than a committed funding source.

Accelerate Resources enters FY2027 with high-grade manganese targets at Woodie Woodie North and new gold zones at Balagundi, but a sharp annual loss and ongoing funding needs remain part of the story. The company plans maiden and follow-up drilling while seeking shareholder approval to rename itself Mango Metals.

PDI Gold’s first full annual report after its Robex merger shows a transformed West African gold business with US$193.7 million in cash and two producing mines. The statutory result remains a US$63.7 million loss, while Bankan’s next phase still depends on an exploitation permit from Guinea.

Cyprium Metals says its long-delayed Nifty Copper Complex is entering the final commissioning phase, with first copper cathode production expected in the December quarter of 2026. The restart is backed by A$121 million in equity raisings, a refinanced US$27.3 million loan facility and A$68.5 million in cash at year-end.

Odyssey Gold has secured a native vegetation clearing permit and a new mining lease at Tuckanarra, while refurbishment work at the planned Kirkalocka processing facility moves ahead. The first toll milling parcel is targeted for June 2027, but a required joint venture agreement remains unresolved.

Barton Gold has moved deeper into development after raising $40.9 million, completing its largest-ever drilling campaign and ending FY2026 with $31.9 million in cash. The progress came alongside a $22.4 million loss as spending accelerated across Tunkillia, Challenger, Tolmer and Wudinna.

Yugo Metals finished 2026 with A$6.29 million in cash after raising A$8.6 million, giving its Bosnia and Herzegovina exploration program more financial room. The trade-off was a net loss of A$3.93 million, more than double the previous year, alongside substantial equity issuance and ongoing funding risk.

Resolution Minerals has turned Horse Heaven into the centre of its strategy, pairing broad gold drilling with high-grade antimony and tungsten test work. The expansion came with a sharply higher A$53.3 million FY2026 loss and a disclosed dependence on future funding.

Novatti has reported a statutory profit and positive EBITDA for FY26 after cutting low-margin revenue and concentrating on Payments AU/NZ. The turnaround is substantial, but an auditor-flagged going-concern uncertainty, upcoming debt maturities and negative operating cash flow leave the recovery unfinished.